Скачать или смотреть when to use double antipsudomonals and when to use cefotaxime for critically ill patient

Are you a healthcare professional looking to understand the appropriate use of cefotaxime and when to apply double antipseudomonal coverage in sepsis?
In this video, Sahar Mohammed Hesham, Board-Certified Infectious Diseases Clinical Pharmacist, explains guideline-based recommendations with practical clinical insights.

🔍 Topics Covered in This Video:

✅ When to use Cefotaxime in community-acquired infections (CAP, meningitis, SBP, neonatal sepsis, cUTI, intra-abdominal infections)

❌ When NOT to use Cefotaxime (HAP, VAP, ESBL, Pseudomonas)

🦠 List of Antipseudomonal Antibiotics

⚠️ Infections at High Risk for Pseudomonas

💉 When to use Single vs. Double Antipseudomonal Coverage in septic shock or MDR risk

🔑 Antimicrobial stewardship: empiric therapy, targeted therapy, and de-escalation

📖 Guidelines Referenced:

IDSA/ATS CAP Guidelines (2019)

IDSA Bacterial Meningitis Guidelines (2017)

AASLD SBP Guidelines (2021)

IDSA/SIS Intra-abdominal Infection Guidelines (2017)

IDSA/ATS HAP-VAP Guidelines (2016)

Surviving Sepsis Campaign Guidelines (2021)

IDSA AMR Guidance (2022)

🎯 Who is this video for?

Clinical pharmacists

Infectious diseases physicians

ICU doctors and critical care teams

Medical residents & pharmacy students

Healthcare professionals preparing for board exams

📞 For consultations, collaborations, or infectious diseases training courses, you can contact me directly at:
👉 +971502048101

👉 Don’t forget to subscribe for more infectious diseases and antimicrobial stewardship updates.
👍 Like, comment, and share this video to spread evidence-based practice.

#Cefotaxime #Antibiotics #InfectiousDiseases #Sepsis #Pseudomonas #AntimicrobialStewardship #ClinicalPharmacy #IDSA #CriticalCare